POZ - Latino Hub : News : FDA Warns Abbott Over Kaletra Ad Featuring Magic Johnson

POZ Latino / Hispanic Hub
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
 

Back to home » News & Views » News


 

February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007


emailrssprint

July 24, 2009

FDA Warns Abbott Over Kaletra Ad Featuring Magic Johnson

The U.S. Food and Drug Administration (FDA) has issued a warning letter to Abbott Laboratories regarding a promotional DVD in which HIV-positive basketball Hall of Famer Earvin “Magic” Johnson discusses his experiences with HIV medication Kaletra, Bloomberg reports.

According to the letter, which was posted on the agency’s website, the video “minimizes the serious risks” and “overstates the efficacy” of the treatment. According to company spokeswoman Michelle Johnson, Abbott stopped using the consumer-targeted DVD earlier this year and will cooperate with the FDA to address these concerns.

In 2004, the FDA issued Abbott a separate warning over a print advertisement for Kaletra that did not include risk information and made unverified implications that patients taking the drug can expect to be healthy for at least five years. The FDA affirms that such promotions are misleading and in violation of federal law.

“The violations described [in the letter] are serious,” wrote Thomas Abrams, director of the FDA’s division of drug marketing. In the warning, the agency ordered Abbott to submit a plan to “disseminate truthful, non-misleading and complete corrective messages about the issues discussed in this letter.”

NEW! Scroll down to comment on this story.

emailrssprint

 

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

         


[Go to top]

Protesters hold the Hershey Company and its affiliated school accountable for condoning HIV-related discrimination. Click here to read more.
What to do if you've just been diagnosed
Qué hacer si eres recién diagnosticado

How to find a support system
Cómo encontrar un sistema de apoyo

Things you should know before starting treatment
Cosas que deberías saber antes de comenzar un tratamiento

How to handle side effects and other concerns
Cómo tratar los efectos secundarios y otros problemas de salud

How to tell someone you have HIV/AIDS
Cómo revelar tu diagnóstico de VIH/SIDA
[an error occurred while processing this directive]
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.